Target intelligence / Profile preview

Clostridioides difficile RNA polymerase switch region (CdRNAP switch region)

Target
CdRNAP switch region
Molecular classification
Enzyme, Bacterial RNA polymerase
01

Overview

The Clostridioides difficile RNA polymerase switch region is a critical regulatory hinge located at the base of the enzyme's mobile clamp module, primarily formed by the intersection of the beta and beta-prime subunits (Srivastava et al., 2011). This region acts as a mechanical pivot that allows the clamp to open and close, a movement essential for the entry of promoter DNA into the active site channel and the subsequent formation of the open promoter complex during transcription initiation (Boyaci et al., 2018). In the context of Clostridioides difficile infection, this switch region serves as the specific binding site for the macrocyclic antibiotic fidaxomicin (Artsimovitch et al., 2012). By binding to the switch region, fidaxomicin traps the RNA polymerase in a state that cannot initiate transcription, effectively halting the production of bacterial mRNA and proteins (Lin et al., 2018). Because the structural architecture of the bacterial switch region is distinct from that of eukaryotic RNA polymerases, it represents a highly selective target for narrow-spectrum antimicrobial therapy with minimal impact on the host or non-target commensal bacteria (Villain-Guillot et al., 2007). Resistance to drugs targeting this region typically arises through point mutations in the rpoB gene, which alter the binding pocket without compromising essential enzyme function (Leeds et al., 2014).

Other names
RNAP switch regionRNA polymerase clamp baseSwitch region of RNA polymeraseRNAP switch-regionFidaxomicin binding site
02

Mechanism of action

Inhibition of transcription initiation by binding to the RNA polymerase switch region and preventing the formation of the open promoter complex (Srivastava et al., 2011).

03

Biological functions

Transcription initiationRNA synthesisDNA binding
04

Disease associations

InfectionClostridioides difficile infectionPseudomembranous colitis
05

Safety considerations

Emergence of resistance via rpoB mutationsHypersensitivity reactionsGastrointestinal hemorrhage
06

Interacting drugs

Fidaxomicin

3 more in the full profile.

07

Biomarkers

rpoB gene mutationsClostridioides difficile toxin AClostridioides difficile toxin B

Beyond the preview

Go deeper on Clostridioides difficile RNA polymerase switch region (CdRNAP switch region).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile RNA polymerase switch region (CdRNAP switch region).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call